95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
44.37%
Revenue growth at 75-90% of NEM's 57.24%. Bill Ackman would push for innovation or market expansion to catch up.
43.20%
Positive gross profit growth while NEM is negative. John Neff would see a clear operational edge over the competitor.
47.82%
Positive EBIT growth while NEM is negative. John Neff might see a substantial edge in operational management.
47.82%
Positive operating income growth while NEM is negative. John Neff might view this as a competitive edge in operations.
44.74%
Positive net income growth while NEM is negative. John Neff might see a big relative performance advantage.
52.00%
Positive EPS growth while NEM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
52.00%
Positive diluted EPS growth while NEM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.01%
Share reduction more than 1.5x NEM's 23.02%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.02%
Diluted share reduction more than 1.5x NEM's 22.86%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
3.51%
Dividend growth under 50% of NEM's 17.84%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
45.21%
Positive OCF growth while NEM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-388.43%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
51.80%
Positive 10Y revenue/share CAGR while NEM is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
60.74%
5Y revenue/share CAGR above 1.5x NEM's 4.31%. David Dodd would look for consistent product or market expansions fueling outperformance.
11.68%
Positive 3Y CAGR while NEM is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
57.33%
Positive long-term OCF/share growth while NEM is negative. John Neff would see a structural advantage in sustained cash generation.
124.71%
Positive OCF/share growth while NEM is negative. John Neff might see a comparative advantage in operational cash viability.
18.55%
Positive 3Y OCF/share CAGR while NEM is negative. John Neff might see a big short-term edge in operational efficiency.
41.52%
Positive 10Y CAGR while NEM is negative. John Neff might see a substantial advantage in bottom-line trajectory.
2319.88%
Positive 5Y CAGR while NEM is negative. John Neff might view this as a strong mid-term relative advantage.
6.30%
Positive short-term CAGR while NEM is negative. John Neff would see a clear advantage in near-term profit trajectory.
62.87%
10Y equity/share CAGR 1.25-1.5x NEM's 46.46%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
31.82%
5Y equity/share CAGR at 50-75% of NEM's 50.63%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
20.68%
3Y equity/share CAGR above 1.5x NEM's 3.46%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
68.43%
10Y dividend/share CAGR at 50-75% of NEM's 131.26%. Martin Whitman suspects the firm lags in returning cash to shareholders over the decade.
95.52%
Below 50% of NEM's 234.99%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
45.29%
3Y dividend/share CAGR above 1.5x NEM's 18.14%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-1.94%
Firm’s AR is declining while NEM shows 1473.08%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-43.80%
Inventory is declining while NEM stands at 35.07%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.74%
Asset growth well under 50% of NEM's 45.75%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.55%
Under 50% of NEM's 23.26%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.75%
We’re deleveraging while NEM stands at 56.99%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
26.62%
SG&A growth well above NEM's 20.00%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.